| |

Study Asks What is the Best Mesothelioma Surgery?

ByAlex Strauss

best mesothelioma surgeryThe best mesothelioma surgery is the one the patient can tolerate with the fewest serious side effects. That’s according to a new study from MD Anderson researchers.

Their goal was to help settle the ongoing debate over which type of pleural mesothelioma surgery is most effective. 

Both EPP and P/D surgery are major operations. But one causes much more serious side effects than the other. So how do doctors and patients decide on the best mesothelioma surgery for their case?

The new research suggests there may not be a definitive answer. 

Debate Over the Best Mesothelioma Surgery

Pleural mesothelioma is an asbestos-linked cancer of the membrane around the lungs. During EPP (extrapleural pneumonectomy) surgery, doctors remove this membrane, any other evidence of cancer, and the closest lung. 

Some of the top mesothelioma doctors in the world believe that EPP is the best mesothelioma surgery because it removes more of the cancer. But it is a risky operation with a high rate of complications and even death.

In some ways, P/D surgery (pleurectomy with decortication) is similar to EPP. Surgeons remove as much diseased tissue as they can see. They scrape any evidence of cancer away from the surface of the lungs. But they do not remove either of the lungs. Many surgeons now think P/D is the best mesothelioma surgery because it is easier on the patient.

No Clear Answer

Studies comparing the two surgeries have produced mixed results. Centers that do more EPP surgeries are likely to have better results with this operation. The same is true with centers that do more P/D. The MD Anderson team tried to make all things equal for a fair determination of the best mesothelioma surgery. 

They started with a list of 282 pleural mesothelioma patients. These patients had operations at MD Anderson between 2000 and 2019. One hundred and eighty-seven of these patients underwent EPP. The remaining 95 had P/D.

“Even with propensity score matching, perioperative mortality was significantly higher for EPP than for P/D,” says lead author Nicolas Zhou. 

But those deaths do not tell the whole story of which is the best mesothelioma surgery. Several factors played a role in how long patients survived after either operation. 

People with the most complete removal of their tumors, those with the epithelioid subtype, those who had radiation afterward, and those who had their operations more recently all did better – regardless of which operation they had.

“In a multimodality treatment setting, P/D and EPP had comparable long-term oncological outcomes,” writes Dr. Zhou.

The study does not recommend one surgery over the other. Instead, Dr. Zhou and his colleagues say the best mesothelioma surgery is the one that is best suited for the patient’s subtype, treatment plan, and overall health.

“The goal of surgical cytoreduction should be macroscopic complete resection achieved by the safest operation a patient can tolerate,” they write. 

Source:

Zhou, N, et al, “Extrapleural Pneumonectomy versus Pleurectomy/Decortication for Malignant Pleural Mesothelioma”, May 7, 2021, Annals of Thoracic Surgery, Online ahead of print, https://www.annalsthoracicsurgery.org/article/S0003-4975(21)00846-8/pdf

Similar Posts

  • | |

    Doctors Describe "Concrete Therapeutic Approach" for Mesothelioma

    ByAlex Strauss

    A team of medical researchers in Italy have achieved what they are calling “excellent” tumor control and survival results in malignant pleural mesothelioma patients using a combination of surgery, chemotherapy, and radiotherapy. Caused by exposure to asbestos, mesothelioma typically spreads quickly across the lung-encasing membrane called the pleura. There is no known cure but treatments are improving. In the current prospective study, 20 malignant pleural mesothelioma patients underwent radical pleurectomy/decortication followed by high doses of radiation. After surgeons removed as much of the visible mesothelioma tumor and surrounding tissue as possible, patients received 50Gy of radiation to the effected side of their chest, delivered in 25 fractions. Regions of particular concern for mesothelioma regrowth got an extra radiation “boost” to…

  • | |

    Does Radiotherapy Reduce Mesothelioma Pain?

    ByAlex Strauss

    A new study says there is not enough evidence to support the use of radiotherapy for the treatment of pain associated with malignant pleural mesothelioma. Researchers at the University of Edinburgh in Scotland reviewed a range of past studies on mesothelioma pain and radiotherapy by searching databases that date back as far as 1974. To be eligible to be included in their review, the study had to focus on malignant pleural mesothelioma and radiotherapy given “with the intent of improving pain”. The study also had to report doses and fractionation of the radiotherapy and how the pain responded. In all, the researchers found eight studies on mesothelioma pain and radiotherapy that met the criteria. Two of the studies were prospective…

  • | |

    Radiotherapy for Mesothelioma: Better But Still Limited

    ByAlex Strauss

    A form of highly-targeted radiation therapy for mesothelioma is better than it used to be, but is still risky. That is the message of a recent article on intensity-modulated radiation therapy (IMRT) in Seminars in Thoracic and Cardiovascular Surgery. Author Kenneth E. Rosenzweig, MD, a Radiation Oncologist with Mount Sinai Hospital in New York, reviewed recent studies on IMRT and mesothelioma. He concludes that, while the “troubling toxicity” associated with IMRT when it was first introduced has not been entirely eliminated, the fact that clinicians now have more experience with it is making a positive difference for mesothelioma patients. Before targeted therapies like IMRT were available, high-dose radiation was not usually a feasible option for mesothelioma since the irregular shape…

  • | |

    A Second-Line Option for Mesothelioma?

    ByAlex Strauss

    Although survival was not significantly extended, the chemotherapy drug vinorelbine might be a treatment option for mesothelioma patients whose cancer has returned after first-line chemotherapy with pemetrexed. A new study on vinorelbine as a second-line treatment finds that the drug is “moderately active” in mesothelioma patients who were initially treated with pemetrexed-based chemotherapy. Pemetrexed (Alimta), along with a platinum-based drug like cisplatin, is the primary first-line drug therapy for mesothelioma. But vinorelbine is gaining attention as a possible option for mesothelioma, in part because it is available in a less expensive generic form. In “Vinorelbine in pemetrexed-pretreated patients with malignant pleural mesothelioma”, the Italian authors detail the results of their study on 59 patients with unresectable pleural mesothelioma.  These patients…

  • | |

    Repeat HIPEC Improves Mesothelioma Survival

    ByAlex Strauss

    If one cytoreductive surgery and HIPEC procedure for mesothelioma is good, subsequent treatments may be even better. That is the central message of research conducted at the Moffitt Cancer Center in Florida. The study’s aim was to assess overall survival among peritoneal mesothelioma patients who had not just one, but two or more rounds of heated intraperitoneal chemotherapy (HIPEC) after cytoreductive surgery. The cytoreduction/HIPEC approach has become popular for peritoneal mesothelioma, a treatment-resistant cancer of abdominal membranes caused by asbestos. Cytoreductive surgery involves removing as much of the mesothelioma tumor as possible from the abdomen. Because the shape and spreading pattern of mesothelioma tumors make complete cytoreduction difficult, the surgery is often followed by a rinse with a heated solution…

  • | |

    Value of Mesothelioma Surgery Challenged for Healthy Patients

    ByAlex Strauss

    New research conducted in Italy and presented at the 15th World Conference on Lung Cancer in Sydney, Australia suggests that mesothelioma surgery – no matter what kind – may not offer a survival advantage over medical management for the healthiest of patients. Mesothelioma is a rare but aggressive malignancy that is highly resistant to standard cancer treatments. The two types of mesothelioma surgery considered to be options for people with resectable cancer are pleurectomy decortication (P/D) or extrapleural pneumonectomy (EPP). While EPP is more radical than P/D because it involves removing a lung, both carry a heavy risk of complications and, according to the Italian researchers, may not be of value for certain patients. The study reviewed data from 1,365…